{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:52:11Z","timestamp":1789991531095,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.biomaterials.2014.04.037","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T22:15:59Z","timestamp":1399068959000},"page":"6130-6141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Hepatitis B virus preS1-derived lipopeptide functionalized liposomes for targeting of hepatic cells"],"prefix":"10.1016","volume":"35","author":[{"given":"Xuanmiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2014.04.037_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2012.02.011","article-title":"Drug targeting to the diseased liver","volume":"161","author":"Poelstra","year":"2012","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib2","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jhep.2011.05.039","article-title":"Nanotechnology for therapy and imaging of liver diseases","volume":"55","author":"Reddy","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2012.12.017","article-title":"N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver","volume":"166","author":"Wang","year":"2013","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib4","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.biomaterials.2008.12.074","article-title":"Cationic glycolipids with cyclic and open galactose head groups for the selective targeting of genes to mouse liver","volume":"30","author":"Mukthavaram","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib5","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.actbio.2010.04.021","article-title":"Glycyrrhetinic acid-modified poly (ethylene glycol)-b-poly (\u03b3-benzyl L-glutamate) micelles for liver targeting therapy","volume":"6","author":"Huang","year":"2010","journal-title":"Acta Biomater"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib6","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1016\/j.biomaterials.2010.02.042","article-title":"Glycyrrhetinic acid-modified chitosan\/poly (ethylene glycol) nanoparticles for liver-targeted delivery","volume":"31","author":"Tian","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nm0395-221","article-title":"Selective liver targeting of antivirals by recombinant chylomicrons \u2013 a new therapeutic approach to hepatitis B","volume":"1","author":"Rensen","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2010.03.010","article-title":"Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics","volume":"145","author":"Hirata","year":"2010","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-3659(02)00006-8","article-title":"Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers","volume":"80","author":"Opanasopit","year":"2002","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.gt.3301089","article-title":"Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes","volume":"7","author":"Kawakami","year":"2000","journal-title":"Gene Ther"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/17425247.5.6.703","article-title":"Mannose-targeted systems for the delivery of therapeutics","volume":"5","author":"Irache","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib13","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1021\/mp400216r","article-title":"Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles","volume":"10","author":"Zhu","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0169-409X(01)00109-0","article-title":"Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting","volume":"47","author":"Rensen","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2893.1997.00126.x","article-title":"Organ and species specificity of hepatitis B virus (HBV) infection: a review of literature with a special reference to preferential attachment of HBV to human hepatocytes","volume":"4","author":"Meyer","year":"1997","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib16","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/hep.23150","article-title":"Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models","volume":"50","author":"Deng","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib17","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/JVI.03328-12","article-title":"Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes","volume":"87","author":"Hong","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib18","doi-asserted-by":"crossref","first-page":"e53392","DOI":"10.1371\/journal.pone.0053392","article-title":"Truncated active human matrix metalloproteinase-8 delivered by a chimeric adenovirus-hepatitis B virus vector ameliorates rat liver cirrhosis","volume":"8","author":"Liu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib19","doi-asserted-by":"crossref","first-page":"10818","DOI":"10.1073\/pnas.96.19.10818","article-title":"Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection","volume":"96","author":"Protzer","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-1702(02)00043-6","article-title":"Approach to establishing a liver targeting gene therapeutic vector using naturally occurring defective hepatitis B viruses devoid of immunogenic T cell epitope","volume":"85","author":"Wang","year":"2002","journal-title":"Virus Res"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1015320314201","article-title":"Hepatitis B virus vector carries a foreign gene into liver cells in\u00a0vitro","volume":"24","author":"Yoo","year":"2002","journal-title":"Virus Genes"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bbrc.2009.10.016","article-title":"The \u201cTrojan horse\u201d model-delivery of anti-HBV small interfering RNAs by a recombinant HBV vector","volume":"390","author":"Shlomai","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jconrel.2012.04.008","article-title":"Virus-mediated gene delivery for human gene therapy","volume":"161","author":"Giacca","year":"2012","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib24","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1038\/sj.gt.3302373","article-title":"Liver gene therapy: advances and hurdles","volume":"11","author":"Nguyen","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib25","doi-asserted-by":"crossref","first-page":"e60306","DOI":"10.1371\/journal.pone.0060306","article-title":"Replication-competent Infectious hepatitis B virus vectors carrying substantially sized transgenes by redesigned viral polymerase translation","volume":"8","author":"Wang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib26","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","article-title":"Hepatitis B virus infection-natural history and clinical consequences","volume":"350","author":"Ganem","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jconrel.2011.11.004","article-title":"Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cells","volume":"160","author":"Yamada","year":"2012","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nbt843","article-title":"Nanoparticles for the delivery of genes and drugs to human hepatocytes","volume":"21","author":"Yamada","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2007.12.002","article-title":"Bio-nanocapsule conjugated with liposomes for in\u00a0vivo pinpoint delivery of various materials","volume":"126","author":"Jung","year":"2008","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/abbs\/gmr082","article-title":"Targeted novel surface-modified nanoparticles for interferon delivery for the treatment of hepatitis B","volume":"43","author":"Giri","year":"2011","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10611860500230294","article-title":"Hepatitis B surface protein docked vesicular carrier for site specific delivery to liver","volume":"13","author":"Khatri","year":"2005","journal-title":"J\u00a0Drug Target"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(99)02991-8","article-title":"School-based hepatitis B vaccination programme and adolescent multiple sclerosis","volume":"355","author":"Sadovnick","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/bmj.301.6747.345","article-title":"Hepatitis B vaccine associated with erythema nodosum and polyarthritis","volume":"301","author":"Rogerson","year":"1990","journal-title":"Br Med J"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.autrev.2004.10.002","article-title":"Autoimmune hazards of hepatitis B vaccine","volume":"4","author":"Girard","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200102013440502","article-title":"Hepatitis B vaccination and the risk of multiple sclerosis","volume":"344","author":"Ascherio","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nbt1389","article-title":"Prevention of hepatitis B virus infection in\u00a0vivo by entry inhibitors derived from the large envelope protein","volume":"26","author":"Petersen","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd1331","article-title":"Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes","volume":"3","author":"Matthews","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","article-title":"The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus","volume":"58","author":"Volz","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib39","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/JVI.79.3.1613-1622.2005","article-title":"Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein","volume":"79","author":"Gripon","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hep.26211","article-title":"Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts","volume":"58","author":"Schieck","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib41","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0168-8278(10)60012-8","article-title":"Preclinical studies on Myrcludex B, a novel entry inhibitor for hepatitis B and hepatitis delta virus (HDV) infections","volume":"52","author":"Urban","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib42","first-page":"S57","article-title":"Safety pharmacology, pharmacokinetics and toxicology of Myrcludex B, a first-in-class hepatitis B virus entry inhibitor","volume":"18","author":"Mier","year":"2012","journal-title":"J\u00a0Pept Sci"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib43","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.biomaterials.2011.10.035","article-title":"Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome","volume":"33","author":"Sun","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijpharm.2013.06.053","article-title":"Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS","volume":"454","author":"Xu","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib45","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.1016\/j.biomaterials.2013.07.014","article-title":"A\u00a0pH-responsive \u03b1-helical cell penetrating peptide-mediated liposomal delivery system","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0022-1759(79)90262-X","article-title":"Isolation and characterization of hepatocytes and Kupffer cells","volume":"27","author":"Page","year":"1979","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib47","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jconrel.2008.07.006","article-title":"An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor","volume":"131","author":"Chono","year":"2008","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/hep.26181","article-title":"Myristoylated preS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes","volume":"58","author":"Meier","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jps.1023","article-title":"Trends and developments in liposome drug delivery systems","volume":"90","author":"Lian","year":"2001","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib51","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/toxsci\/kfg064","article-title":"Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in\u00a0vivo liver gene expression in rats: possible implications for toxicogenomics use of in\u00a0vitro systems","volume":"73","author":"Boess","year":"2003","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib52","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib53","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib54","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/0016-5085(94)90821-4","article-title":"In situ localization of the hepatocytic Na+\/taurocholate cotransporting polypeptide in rat liver","volume":"107","author":"Stieger","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib55","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11095-007-9289-1","article-title":"Bile acid transporters: structure, function, regulation and pathophysiological implications","volume":"24","author":"Alrefai","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib56","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/pr.58.1.8","article-title":"Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery","volume":"58","author":"Khalil","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib57","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.1016\/j.biomaterials.2012.07.030","article-title":"Intracellular trafficking mechanism, from intracellular uptake to extracellular efflux, for phospholipid\/cholesterol liposomes","volume":"33","author":"Un","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib58","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1021\/mp2000428","article-title":"Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes","volume":"8","author":"Qhattal","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib59","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jconrel.2006.11.006","article-title":"Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect","volume":"117","author":"Zhang","year":"2007","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nrc1146","article-title":"Caveolae: mining little caves for new cancer targets","volume":"3","author":"Carver","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib62","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/JVI.01207-09","article-title":"Hepatitis B virus requires intact caveolin-1 function for productive infection in HepaRG cells","volume":"84","author":"Macovei","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib63","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/smll.201002020","article-title":"Single-particle tracking of hepatitis B virus-like vesicle entry into cells","volume":"7","author":"Hao","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-4827(87)90262-X","article-title":"Toxicity of non-drug-containing liposomes for cultured human cells","volume":"171","author":"Mayhew","year":"1987","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(96)00456-5","article-title":"Stealth\u00ae liposomes: from theory to product","volume":"24","author":"C\u011bh","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib66","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/JVI.01902-09","article-title":"Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction","volume":"84","author":"Schulze","year":"2010","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib67","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/092986707779941159","article-title":"Silybin and silymarin-new and emerging applications in medicine","volume":"14","author":"Gaz\u00e1k","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib68","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1111\/j.1572-0241.2005.00262.x","article-title":"Milk thistle for alcoholic and\/or hepatitis B or C liver diseases\u2013a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials","volume":"100","author":"Rambaldi","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib69","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/0016-5085(95)90762-9","article-title":"Antioxidant activity of silybin in\u00a0vivo during long-term iron overload in rats","volume":"109","author":"Pietrangelo","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib70","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1021\/jp075814h","article-title":"Mechanism of the antioxidant action of silybin and 2, 3-dehydrosilybin flavonolignans: a joint experimental and theoretical study","volume":"112","author":"Trouillas","year":"2008","journal-title":"J\u00a0Phys Chem A"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib71","doi-asserted-by":"crossref","first-page":"A127","DOI":"10.1016\/j.dld.2008.07.154","article-title":"Silybin is a direct antifibrogenic and antiinflammatory agent: cellular and molecular mechanisms","volume":"40","author":"Trappoliere","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib72","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jhep.2009.02.023","article-title":"Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells","volume":"50","author":"Trappoliere","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.biomaterials.2014.04.037_bib73","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2005.10.016","article-title":"Liver targeting of catalase by cationization for prevention of acute liver failure in mice","volume":"110","author":"Ma","year":"2006","journal-title":"J\u00a0Control Release"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961214004359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961214004359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:59:29Z","timestamp":1758902369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961214004359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":73,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0142961214004359"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2014.04.037","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis B virus preS1-derived lipopeptide functionalized liposomes for targeting of hepatic cells","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2014.04.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}